StockClub

EBS

EBSEmergent BioSolutions Inc.$ --
Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

EBS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
156M USD
YoY -29.7%
Operating Income
11M USD
YoY -78.4%
Net Income
7M USD
YoY -90.0%
EPS
0.13$
YoY -89.6%

Revenue

$156.1M
FY2024 Q2$555.1M
$555.1M
Q2
FY2024 Q3$848.9M
$848.9M
Q3
FY2024 Q4$1B
$1B
Q4
FY2025 Q1$222.2M
$222.2M
Q1
FY2025 Q2$363.1M
$363.1M
Q2
FY2025 Q3$594.2M
$594.2M
Q3
FY2025 Q4$742.9M
$742.9M
Q4
FY2026 Q1$156.1M
$156.1M
Q1
Actual
$-66.1M (-29.7%)

Net Income

$6.8M
FY2024 Q2$-274.1M
$-274.1M
Q2
FY2024 Q3$-159.3M
$-159.3M
Q3
FY2024 Q4$-190.6M
$-190.6M
Q4
FY2025 Q1$68M
$68M
Q1
FY2025 Q2$56M
$56M
Q2
FY2025 Q3$107.2M
$107.2M
Q3
FY2025 Q4$52.6M
$52.6M
Q4
FY2026 Q1$6.8M
$6.8M
Q1
Actual
$-61.2M (-90.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$1.6B
Est:$1.5B
FY2020BEAT
$1.6B
FY2021BEAT
Actual:$1.8B
Est:$1.7B
FY2021BEAT
$1.8B
FY2022BEAT
Actual:$1.1B
Est:$1.1B
FY2022BEAT
$1.1B
FY2023MISS
Actual:$1B
Est:$1.1B
FY2023MISS
$1B
FY2024MISS
Actual:$1B
Est:$1.1B
FY2024MISS
$1B
FY2025MISS
Actual:$742.9M
Est:$809.4M
FY2025MISS
$742.9M

Analyst Estimates